Early stage medically inoperable non-small cell lung cancer

Current Treatment Options in Oncology

Volumn 4, Issue 1, 2003, Pages 81-88

  Bogart, Jeffrey A ^a   Scalzetti, Ernest ^b   Dexter, Elisabeth ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b NONE

Author keywords

Elective Nodal Irradiation; Limited Resection; Lung Cancer Study Group; Radiat Oncol Biol Phys; Sublobar Resection

Indexed keywords

HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS;

EID: 0038048941     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-003-0034-7     Document Type: Article

References (43)

1. Cancer Facts and Figures 2002. Atlanta, GA: American Cancer Society; 2002.
2. Mettlin CJ, Menck HR, Murphy GP, et al.: A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology and End Results Program? Cancer 1997, 79:2052–2061. DOI: 10.1002/(SICI)1097-0142(19970515)79:10<2052::AID-CNCR29>3.0.CO;2-S
3. Williams DE, Pairolero PC, Davis CS, et al.: Survival of patients surgically treated for stage I lung cancer? J Thorac Cardiovasc Surg 1981, 82:70–76.
4. Yancik R: Cancer burden in the aged? Cancer 1997, 80:1273–1283. DOI: 10.1002/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4
5. Henschke CI, McCauley DI, Uankelevitz DF, et al.: Early lung cancer action project: overall design and findings from baseline screening? Lancet 1999, 354:99–105. Detailed findings of a prospective trial evaluating low-dose spiral CT scan screening for patients at high risk for NSCLC. DOI: 10.1016/S0140-6736(99)06093-6
6. Gauden S, Ramsay J, Tripcony L: The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung? Chest 1995, 108:1278–1282. The largest single-institution analysis of radiotherapy for early stage NSCLC.
7. Miller JI, Hatcher CR: Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function? Ann Thorac Surg 1987, 44:340–343. DOI: 10.1016/S0003-4975(10)63785-X
8. Pastorino U, Valente M, Bedini V, et al.: Results of conservative surgery for stage I lung cancer? Tumori 1990, 76:38–43.
9. Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group? Ann Thorac Surg 1995, 60:622–623. Prospective trial detailing the superiority of lobectomy for stage I NSCLC in fit patients. DOI: 10.1016/0003-4975(95)00537-U
10. Weisman IM: Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery? Semin Thorac Cardiovasc Surg 2001, 13:116–125. DOI: 10.1053/stcs.2001.24619
11. Errett LE, Wilson J, Chiu RC, et al.: Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients? J Thorac Cardiovasc Surg 1985, 90:656–661.
12. Mentzer SJ, DeCamp MM, Harpole DH Jr, et al.: Thoracoscopy and video-assisted thoracic surgery in the treatment of lung cancer? Chest 1995, 107:298S-301S.
13. Shennib H, Bogart JA, Herndon J, et al.: Thorascopic wedge resection and radiotherapy for T1N0 non-small cell lung cancer (NSCLC) in high risk patients: preliminary analysis of a Cancer and Leukemia Group B and Eastern Cooperative Oncology Group phase II trial [abstract]? Int J Radiat Oncol Biol Phys 2000, 48:232. Initial report of the first prospective cooperative group trial evaluating therapy for patients with stage I NSCLC and cardiopulmonary dysfunction. DOI: 10.1016/S0360-3016(00)80257-6
14. Dieter RJ, Kuzycz GB: Complications and contraindications of thoracoscopy? Int Surg 1997, 82:232–239.
15. Parekh K, Rusch V, Baines M, et al.: VATS port site recurrence: a technique dependent problem? Ann Surg Oncol 2001, 8:175–178. DOI: 10.1007/s10434-001-0175-5
16. Bogart J, Shennib H, Kohman L, et al.: Postoperative radiotherapy following thorascopic wedge resection of T1 non-small cell lung cancer in high risk patients: a Cancer and Acute Leukemia Group B and Eastern Cooperative Oncology Group phase II trial [abstract]? Proc Am Soc Clin Oncol 2000, 19:488a.
17. Postoperative radiotherapy in non-small-cell lung cancer: systemic review and meta-analysis of individual patient data from nine randomized controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998, 352:257–263. Overview suggesting a detriment for the use of postoperative radiotherapy in patients with early stage NSCLC.
18. Trodella L, Granone P, Valente S, et al.: Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial? Radiother Oncol 2002, 62:11–19. Prospective randomized trial showing a survival benefit for patients receiving postoperative radiotherapy for stage I NSCLC. DOI: 10.1016/S0167-8140(01)00478-9
19. Chen A, Galloway M, Landreneau R, et al.: Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma? Int J Radiat Oncol Biol Phys 1999, 44:1057–1063. DOI: 10.1016/S0360-3016(99)00133-9
20. Rowell NP, Williams CJ: Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review? Thorax 2001, 56:628–638. Comprehensive review of radiotherapy in the treatment of patients with medically inoperable NSCLC. DOI: 10.1136/thorax.56.8.628
21. Sibley GS: Radiotherapy for patients with medically inoperable stage I non-small cell lung carcinoma? Cancer 1998, 82:433–438. DOI: 10.1002/(SICI)1097-0142(19980201)82:3<433::AID-CNCR2>3.0.CO;2-Q
22. Krol A, Aussems P, Noordijk EM, et al.: Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996, 34:297–302. DOI: 10.1016/0360-3016(95)00227-8
23. Graham PH, Gebski VJ, Langlands AO: Radical radiotherapy for early stage non-small cell lung cancer? Int J Radiat Oncol Biol Phys 1995, 31:261–266. DOI: 10.1016/0360-3016(94)E0137-9
24. Dosoretz DE, Katin MJ, Blitzer PH, et al.: Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies? Int J Radiat Oncol Biol Phys 1992, 24:3–9.
25. Morita K, Kuwa N, Suzuki Y, et al.: Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients? Radiother Oncol 1997, 42:31–36. DOI: 10.1016/S0167-8140(96)01828-2
26. Abratt RP: Modeling tumor and treated lung volume influences in the irradiation of non-small cell lung cancer patients? Int J Radiat Oncol Biol Phys 2001, 49:481–485. DOI: 10.1016/S0360-3016(00)01487-5
27. Graham MV, Winter K, Purdy JA, et al.: Preliminary results of a Radiation Therapy Oncology Group trial (RTOG 9311), a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer [abstract]? Int J Radiat Oncol Biol Phys 2001, 51:19–20. DOI: 10.1016/S0360-3016(01)01858-2
28. Hayman JA, Martel MK, Ten Haken RK, et al.: Dose escalation in non-small-cell lung cancer using threedimensional conformal radiation therapy: update of a phase I trial? J Clin Oncol 2001, 19:127–136.
29. Bradley JD, Ieumwananonthachai N, Purdy JA, et al.: Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma? Int J Radiat Oncol Biol Phys 2002, 52:49–57. DOI: 10.1016/S0360-3016(01)01772-2
30. Willner J, Caragiani E, Tschammler A, et al.: The influence of total dose and tumor volume on local control and survival in non-small cell lung cancer [abstract]? Int J Radiat Oncol Biol Phys 2000, 48:327. DOI: 10.1016/S0360-3016(00)80458-7
31. Mehta M, Scrimger R, Mackie R, et al.: A new approach to dose escalation in non-small-cell lung cancer? Int J Radiat Oncol Biol Phys 2001, 49:23–33. Details the rationale for radiation dose escalation without extending the time to complete treatment. DOI: 10.1016/S0360-3016(00)01374-2
32. Sugi K, Nawata K, Fujita N, et al.: Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter? World J Surg 1998, 22:290–294. DOI: 10.1007/s002689900384
33. Rosenzweig KE, Sim SE, Mychalczak B, et al.: Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy? Int J Radiat Oncol Biol Phys 2001, 50:681–685. DOI: 10.1016/S0360-3016(01)01482-1
34. Langenduk JA, Aaronson NK, De Jong JMA, et al.: Quality of life after curative radiotherapy in stage I non-small-cell lung carcinoma? Int J Radiat Oncol Biol Phys 2002, 53:847–853. Unique trial measuring long-term quality of life after radiotherapy of patients with stage I NSCLC. DOI: 10.1016/S0360-3016(02)02847-X
35. Dupuy DE, Zagoria RJ, Akerley W, et al.: Percutaneous radiofrequency ablation of malignancies in the lung? Am J Roentgenol 2000, 174:57–59.
36. Wood BJ, Ramkaransingh JR, Fojo T, et al.: Percutaneous tumor ablation with radiofrequency? Cancer 2002, 94:443–451. DOI: 10.1002/cncr.10234
37. Furuse K, Fukuoka M, Kawahara M, et al.: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer? J Clin Oncol 1999, 17:2692–2699. Initial prospective trial demonstrating the superiority of concurrent chemoradiotherapy (over sequential therapy) for patients with locally advanced NSCLC.
38. Curran WJ Jr, Scott C, Langer C, et al.: Phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): initial report of Radiation Therapy Oncology Group (RTOG) 9410 [abstract]? Proc Am Soc Clin Oncol 2002, 19:484a.
39. Arteaga CL, Johnson DH: Tyrosine kinase inhibitors-ZD1839 (Iressa)? Curr Opin Oncol 2001, 13:491–498. DOI: 10.1097/00001622-200111000-00012
40. Uematsu MD, Shioda A, Suda A, et al.: Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a 5-year experience? Int J Radiat Oncol Biol Phys 2001, 51:666–670. DOI: 10.1016/S0360-3016(01)01703-5
41. Onimaru R, Shirato H, Shimizul S, et al.: Tumor control and respiratory function after stereotactic irradiation (STI) for primary and metastatic lung cancer [abstract]? Int J Radiat Oncol Biol Phys 2001, 51:345. DOI: 10.1016/S0360-3016(01)02460-9
42. Nagata Y, Negoro T, Aoki T, et al.: Clinical outcomes of 3-D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame [abstract]? Int J Radiat Oncol Biol Phys 2001, 51:352–353. DOI: 10.1016/S0360-3016(01)02473-7
43. Hara R, Itami J, Kondo T, et al.: Stereotactic single high dose irradiation of lung tumors under respiratory gating? Radiother Oncol 2002, 63:159–163. DOI: 10.1016/S0167-8140(02)00063-4